High Dose Vitamin C and Cancer

High Dose Vitamin C and Cancer

 

 

From the tumor biology perspective, cancer cells survive better when there is inflammation. So the presence of inflammation, as well as other factors (such as hypoxia or lack of oxygen, blood acidity, and lower immunity), can facilitate cancer growth and spread. This article will discuss the High Dose of Vitamin C and Cancer.

Medical, Surgical, and Radiation Oncology are the foundation for Conventional Cancer care in addition to the hormonal treatments and the recently introduced targeted agents. The use of the High Dose Intravenous Vitamin C is one of the most important and commonly used treatment modalities from the Naturopathic Medical aspect.

According to research published in 2012 in the Journal of Translational Medicine, a group of scientists interested in the natural means to help cancer patients started to study the effects of giving the high doses of intravenous vitamin C on the inflammation markers of patients with different types of cancers (such as prostate cancer, breast cancer, bladder cancer, pancreatic cancer, lung cancer, thyroid cancer, skin cancer, and B-cell lymphoma) by comparing these inflammation markers  (such as CRP or C Reactive protein) before giving the High Dose intravenous vitamin C and after the infusion.

They studied 45 patients with different types of cancers (as explained before) and compared their CRP (C Reactive Protein) levels before and after the High Dose Intravenous Vitamin C. All the patients when they were enrolled in that study had already completed their conventional treatments (such as chemotherapy, Radiation Therapy, or targets agents)

The scientists found that, after receiving the High Dose Intravenous Vitamin C, there was a reduction in the inflammation marker (CRP or C Reactive Protein) in a many as 75% of patients, and only 25% demonstrated an increase in their inflammation markers.

 

So, it was concluded that the administration of the High Dose Intravenous Vitamin C for Cancer Patients was very helpful in reducing the inflammation marker which means a better anti-cancer environment and possibly more control and reduction of the cancer cell survival, and possibly spread.

If you need more details about this research you can click this link:

https://pubmed.ncbi.nlm.nih.gov/22963460/

 

If you have any questions or have a patient with cancer or under oncology care don’t hesitate to contact us

Toronto Office  https://www.ontarionaturopathicclinic.ca/site/contact-toronto 

Grimsby Office https://www.ontarionaturopathicclinic.ca/site/contact-grimsby